Back
Mineralys Therapeutics Stock Price Chart
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
MLYS
Mineralys Therapeutics
Last Price:
$16.87
Seasonality Move:
-0.62%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLYS is experiencing slight selling pressure.
Mineralys Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.11 | Buy |
| 20-day SMA: | 12.09 | Buy |
| 50-day SMA: | 10.93 | Buy |
| 200-day SMA: | 12.16 | Buy |
| 8-day EMA: | 15.19 | Buy |
| 20-day EMA: | 13.13 | Buy |
| 50-day EMA: | 11.87 | Buy |
| 200-day EMA: | 12.01 | Buy |
Mineralys Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 74.93 | Buy |
| Chaikin Money Flow: | -97027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.99 - 14.35) | Buy |
| Bollinger Bands (100): | (10.02 - 13.8) | Buy |
Mineralys Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mineralys Therapeutics Stock
Is Mineralys Therapeutics Stock a Buy?
-
Mineralys Therapeutics share price is 16.87 while MLYS 8-day simple moving average is 15.11, which is a Buy signal.
-
The stock price of MLYS is 16.87 while Mineralys Therapeutics 20-day SMA is 12.09, which makes it a Buy.
-
Mineralys Therapeutics 50-day simple moving average is 10.93 while MLYS share price is 16.87, making it a Buy technically.
-
MLYS stock price is 16.87 and Mineralys Therapeutics 200-day simple moving average is 12.16, creating a Buy signal.
MLYS Technical Analysis vs Fundamental Analysis
Buy
70
Mineralys Therapeutics (MLYS)
is a Buy
Is Mineralys Therapeutics a Buy or a Sell?
-
Mineralys Therapeutics stock is rated a BuyThe current Mineralys Therapeutics [MLYS] share price is $16.87. The Score for MLYS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Mineralys Therapeutics Stock Info
Market Cap:
1.1B
Price in USD:
16.87
Share Volume:
832.4K
Mineralys Therapeutics 52-Week Range
52-Week High:
18.38
52-Week Low:
8.24
Buy
70
Mineralys Therapeutics (MLYS)
is a Buy
Mineralys Therapeutics Share Price Forecast
-
What is the Mineralys Therapeutics stock price today?The Mineralys Therapeutics stock price is 16.87 USD today.
-
Will MLYS stock go up or go down?Mineralys Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mineralys Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mineralys Therapeutics is not overvalued.
Is Mineralys Therapeutics Stock a Buy?
-
Mineralys Therapeutics share price is 16.87 while MLYS 8-day exponential moving average is 15.19, which is a Buy signal.
-
The stock price of MLYS is 16.87 while Mineralys Therapeutics 20-day EMA is 13.13, which makes it a Buy.
-
Mineralys Therapeutics 50-day exponential moving average is 11.87 while MLYS share price is 16.87, making it a Buy technically.
-
MLYS stock price is 16.87 and Mineralys Therapeutics 200-day simple moving average is 12.01, creating a Buy signal.
Fundamental Analysis of Mineralys Therapeutics
Is Mineralys Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Mineralys Therapeutics
Should I short Mineralys Therapeutics stock?
-
MLYS Moving Average Covergence Divergence (MACD) indicator is 1.67, suggesting Mineralys Therapeutics is a Buy
-
Mineralys Therapeutics Relative Strength Index (RSI) is 74.93, which suggest Mineralys Therapeutics is overbought
-
The Bollinger Bands (25) for Mineralys Therapeutics is (8.99 - 14.35), which suggest Mineralys Therapeutics is a Buy
-
The Bollinger Bands (100) for Mineralys Therapeutics is (10.02 - 13.8), which suggest Mineralys Therapeutics is a Buy
* Mineralys Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.